Low molecular weight heparin versus minidose unfractionated heparin for prophylaxis against venous thromboembolism in medical intensive care unit patients: A randomized controlled trial

被引:0
|
作者
Goldhaber, SZ
Kett, DH
Cusumano, CJ
Kuroki, CA
机构
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:325A / 325A
页数:1
相关论文
共 50 条
  • [41] A RANDOMIZED DOUBLE-BLIND TRIAL OF LOW-MOLECULAR-WEIGHT HEPARIN FOR PROPHYLAXIS OF THROMBOEMBOLISM IN MEDICAL INPATIENTS
    HARENBERG, J
    ROEBRUCK, P
    HEINRICH, F
    SCHMITZHUEBNER, U
    HEENE, DL
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 648 - 648
  • [42] Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer
    Akl, Elie A.
    Kahale, Lara
    Sperati, Francesca
    Neumann, Ignacio
    Labedi, Nawman
    Terrenato, Irene
    Barba, Maddalena
    Sempos, Elena V.
    Muti, Paola
    Cook, Deborah
    Schuenemann, Holger
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (06):
  • [43] Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer
    Akl, Elie A.
    Labedi, Nawman
    Terrenato, Irene
    Barba, Maddalena
    Sperati, Francesca
    Sempos, Elena V.
    Muti, Paola
    Cook, Deborah
    Schuenemann, Holger
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (11):
  • [44] COMPARISON OF SUBCUTANEOUS UNFRACTIONATED HEPARIN WITH A LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN(R)) IN PATIENTS WITH VENOUS THROMBOEMBOLISM AND CONTRAINDICATIONS TO COUMARIN
    MONREAL, M
    LAFOZ, E
    OLIVE, A
    DELRIO, L
    VEDIA, C
    THROMBOSIS AND HAEMOSTASIS, 1994, 71 (01) : 7 - 11
  • [45] Low molecular weight heparin for venous thromboembolism prophylaxis in general Intensive Care Unit patients: an anti-factor Xa level-based approach
    Zohar, Nitzan
    Ellis, Martin H.
    Dichtwald, Sara
    Meyer, Avraham
    Zohar, Edna
    Ifrach, Nisim
    MINERVA ANESTESIOLOGICA, 2023, 89 (05) : 425 - 433
  • [46] Low-molecular-weight or Unfractionated Heparin in Venous Thromboembolism: The Influence of Renal Function
    Trujillo-Santos, Javier
    Schellong, Sebastian
    Falga, Conxita
    Zorrilla, Vanessa
    Gallego, Pedro
    Barron, Manuel
    Monreal, Manuel
    AMERICAN JOURNAL OF MEDICINE, 2013, 126 (05): : 425 - U149
  • [47] Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients A Systematic Review and Meta-analysis
    Tran, Alexandre
    Fernando, Shannon M.
    Carrier, Marc
    Siegal, Deborah M.
    Inaba, Kenji
    Vogt, Kelly
    Engels, Paul T.
    English, Shane W.
    Kanji, Salmaan
    Kyeremanteng, Kwadwo
    Lampron, Jacinthe
    Kim, Dennis
    Rochwerg, Bram
    ANNALS OF SURGERY, 2022, 275 (01) : 19 - 28
  • [48] Unfractionated versus low-molecular-weight heparin for deep venous thrombosis
    Strandness, DE
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09): : 670 - 671
  • [49] Transaminase elevation in patients with unfractionated heparin or low molecular weight heparin for deep venous thrombosis
    Rossi, L
    Girolami, B
    Villalta, S
    Scarano, L
    Marchiori, A
    Girolami, A
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1163 - P1163
  • [50] Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism
    Erkens, Petra M. G.
    Prins, Martin H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (09):